| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director | President &COO +2 more
3 companies
Greenstreet Yvonne is a Chief Executive Officer at ALNYLAM PHARMACEUTICALS, INC. with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 97 sells.
Estimated insider holdings value: $23.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | ALNY Alnylam Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 9,577 | $362.86 | $3,475,156.51 | -0.6% | -13.2% | - | |
| Nov 13, 2025 | ALNY Alnylam Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 25,650 | $452.75 | $11,613,003.42 | -1.8% | -29.0% | - | |
| Oct 2, 2025 | ALNY Alnylam Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 8,924 | $452.05 | $4,034,084.66 | -1.1% | -13.7% | - | |
| Aug 18, 2025 | ALNY Alnylam Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 6,979 | $453.27 | $3,163,345.74 | -1.4% | +0.8% | - | |
| Jun 2, 2025 | ALNY Alnylam Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 50,937 | $305.00 | $15,535,784.00 | -25.0% | +46.0% | -6.5% | |
| Mar 3, 2025 | ALNY Alnylam Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 3,877 | $243.79 | $945,164.88 | -0.6% | +25.7% | +30.9% | |
| Feb 28, 2025 | ALNY Alnylam Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 2,900 | $241.69 | $700,893.68 | -0.4% | +18.7% | +34.9% | |
| Feb 14, 2025 | ALNY Alnylam Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 1,213 | $255.17 | $309,526.58 | -0.1% | +10.5% | +22.6% | |
| Nov 26, 2024 | ALNY Alnylam Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 5,219 | $250.98 | $1,309,852.75 | -1.3% | -1.7% | +75.7% | |
| Aug 20, 2024 | ALNY Alnylam Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 15,000 | $280.00 | $4,200,000.00 | -17.0% | -17.3% | +63.2% |